RNU6-420P

Across TCGA pan-cancer cohorts, RNU6-420P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-420P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RNU6-420P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-420P expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

KICH, BLCA, and BRCA are the cancer types where RNU6-420P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
BLCA	DFS	Tertile	All	0.156	0.629	<.001	63	view →
BRCA	DFS	Tertile	All	0.519	0.904	<.001	60	view →
READ	DFS	Tertile	III,IV	0.255	0.757	.008	45	view →
UVM	OS	Tertile	All	0.248	0.769	.007	36	view →
LIHC	OS	Tertile	All	0.208	0.690	.009	27	view →
LUSC	DFS	Tertile	All	0.850	0.732	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-420P–KICH (DFS)

Open the KICH breakdown →